Tags

Type your tag names separated by a space and hit enter

Outcomes after uterine artery embolization for pedunculated subserosal leiomyomas.
J Vasc Interv Radiol. 2008 May; 19(5):657-61.JV

Abstract

PURPOSE

To assess the safety and efficacy of uterine artery embolization (UAE) treatment of pedunculated subserosal leiomyomas.

MATERIALS AND METHODS

A review of patients undergoing UAE in a 30-month period (July 2004 to December 2006) was performed. Cases in which a pedunculated subserosal tumor (volume>or=4 cm3) was embolized were analyzed. The preprocedural volumes of the pedunculated tumor and uterus and the diameter and vascularity of the tumor and stalk were recorded. Posttreatment sizes of the pedunculated leiomyoma, stalk, and uterus were recorded, as was the presence or absence of complication(s).

RESULTS

A total of 240 patients underwent embolization. Pedunculated subserosal leiomyomas were treated in 16 women, with a technical success rate of 100%. Preprocedural mean tumor and uterine volumes were 372 cm3 and 789 cm3, respectively. The mean stalk diameter was 2.7 cm (range, 0.8-7.8 cm). All pedunculated leiomyomas exhibited enhancement on contrast agent-enhanced magnetic resonance (MR) imaging (n=13) or vascularity on Doppler ultrasonography (US; n=3). Stalk vascularity was noted on MR imaging in 13 patients and was not assessed in the remaining three, who underwent US imaging. Imaging follow-up (mean, 5.9 months after UAE) demonstrated mean tumor volume reduction of 39.3% (95% confidence interval [CI], 28.2%-50.5%) and mean uterine volume reduction of 37.6% (95% CI, 26%-49.3%). There were no cases of continued tumor perfusion and no major complications. There was one minor complication of prolonged hospital stay (36 hours) for pain control.

CONCLUSION

UAE was successfully and safely performed for pedunculated subserosal leiomyomas, with a tumor volume reduction of 39% and no unique complications related to these lesions.

Authors+Show Affiliations

Department of Medical Imaging, North York General Hospital, University of Toronto, 4001 Leslie Street, Toronto Ontario, Canada M2K 1E1. ryan.margau@utoronto.caNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18440452

Citation

Margau, Ryan, et al. "Outcomes After Uterine Artery Embolization for Pedunculated Subserosal Leiomyomas." Journal of Vascular and Interventional Radiology : JVIR, vol. 19, no. 5, 2008, pp. 657-61.
Margau R, Simons ME, Rajan DK, et al. Outcomes after uterine artery embolization for pedunculated subserosal leiomyomas. J Vasc Interv Radiol. 2008;19(5):657-61.
Margau, R., Simons, M. E., Rajan, D. K., Hayeems, E. B., Sniderman, K. W., Tan, K., Beecroft, J. R., & Kachura, J. R. (2008). Outcomes after uterine artery embolization for pedunculated subserosal leiomyomas. Journal of Vascular and Interventional Radiology : JVIR, 19(5), 657-61. https://doi.org/10.1016/j.jvir.2007.11.022
Margau R, et al. Outcomes After Uterine Artery Embolization for Pedunculated Subserosal Leiomyomas. J Vasc Interv Radiol. 2008;19(5):657-61. PubMed PMID: 18440452.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Outcomes after uterine artery embolization for pedunculated subserosal leiomyomas. AU - Margau,Ryan, AU - Simons,Martin E, AU - Rajan,Dheeraj K, AU - Hayeems,Eran B, AU - Sniderman,Kenneth W, AU - Tan,Kongteng, AU - Beecroft,J Robert, AU - Kachura,John R, Y1 - 2008/03/17/ PY - 2007/07/21/received PY - 2007/11/25/revised PY - 2007/11/27/accepted PY - 2008/4/29/pubmed PY - 2008/9/5/medline PY - 2008/4/29/entrez SP - 657 EP - 61 JF - Journal of vascular and interventional radiology : JVIR JO - J Vasc Interv Radiol VL - 19 IS - 5 N2 - PURPOSE: To assess the safety and efficacy of uterine artery embolization (UAE) treatment of pedunculated subserosal leiomyomas. MATERIALS AND METHODS: A review of patients undergoing UAE in a 30-month period (July 2004 to December 2006) was performed. Cases in which a pedunculated subserosal tumor (volume>or=4 cm3) was embolized were analyzed. The preprocedural volumes of the pedunculated tumor and uterus and the diameter and vascularity of the tumor and stalk were recorded. Posttreatment sizes of the pedunculated leiomyoma, stalk, and uterus were recorded, as was the presence or absence of complication(s). RESULTS: A total of 240 patients underwent embolization. Pedunculated subserosal leiomyomas were treated in 16 women, with a technical success rate of 100%. Preprocedural mean tumor and uterine volumes were 372 cm3 and 789 cm3, respectively. The mean stalk diameter was 2.7 cm (range, 0.8-7.8 cm). All pedunculated leiomyomas exhibited enhancement on contrast agent-enhanced magnetic resonance (MR) imaging (n=13) or vascularity on Doppler ultrasonography (US; n=3). Stalk vascularity was noted on MR imaging in 13 patients and was not assessed in the remaining three, who underwent US imaging. Imaging follow-up (mean, 5.9 months after UAE) demonstrated mean tumor volume reduction of 39.3% (95% confidence interval [CI], 28.2%-50.5%) and mean uterine volume reduction of 37.6% (95% CI, 26%-49.3%). There were no cases of continued tumor perfusion and no major complications. There was one minor complication of prolonged hospital stay (36 hours) for pain control. CONCLUSION: UAE was successfully and safely performed for pedunculated subserosal leiomyomas, with a tumor volume reduction of 39% and no unique complications related to these lesions. SN - 1051-0443 UR - https://www.unboundmedicine.com/medline/citation/18440452/Outcomes_after_uterine_artery_embolization_for_pedunculated_subserosal_leiomyomas_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1051-0443(07)01968-9 DB - PRIME DP - Unbound Medicine ER -